04.05.2024 |
Exploring Nonsense Suppression as a Treatment for NF1 – Phase B
04.05.2024 |
Disrupting FBXW11-Mediated Degradation of NF1 to Rescue Haploinsufficiency
04.05.2024 |
RAFT-Polymerized Nanoparticles for Delivery of NF1 cDNA to Schwann Cells
04.05.2024 |
Genome Editing for the Treatment of Neurofibromatosis Type I
04.05.2024 |
Evaluating a Next Generation AAV Capsid for Targeted Transduction of Schwann Cells
04.05.2024 |
Development of Targeted Gene Therapy Platform for Neurofibromatosis Type I
04.04.2024 |
Creating NF1-CDKN2A-ATRX Models for NF1 Associated High Grade Glioma
04.04.2024 |
Targeting NF1 Mutation Glioma Oncoproteins with Peptide Centric CAR T Cells
04.04.2024 |
hiPSC Modeling of NF1 High-Grade Glioma
04.04.2024 |
Natural History of Neurofibromatosis Type 1-Associated Non-Optic Pathway Low Grade Glioma to Support the Development of Evidence-Based Criteria for Surveillance and Initiation of Treatment
03.27.2024
Detroit Future City Releases New Report: “Keeping Your Family Home: Addressing the Challenges of Inherited Properties in Detroit”
Read
09.18.2024